Study Summary
This trial will test a new digital health platform to help doctors treat patients with depression. The goal is to see if it improves patient outcomes.
- Depression
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
2 Primary · 3 Secondary · Reporting Duration: 3 months
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
Active Control
1 of 2
Active Intervention
1 of 2
Active Control
Experimental Treatment
500 Total Participants · 2 Treatment Groups
Primary Treatment: Clinical Decision Support System · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Georgia | 33.3% |
| Pennsylvania | 16.7% |
| Florida | 16.7% |
| Other | 33.3% |
How old are they?
| 18 - 65 | 75.0% |
| 65+ | 25.0% |
What site did they apply to?
| Yale University, VA Connecticut Healthcare System | 25.0% |
| Sarkis Clinical Trials, Inc. | 25.0% |
| Emory University | 25.0% |
| Other | 25.0% |
What portion of applicants met pre-screening criteria?
| Did not meet criteria | 20.0% |
| Met criteria | 80.0% |
Why did patients apply to this trial?
- "I've finally decided to love forward in addressing my medical condition of depression. I was against using the pharmaceutical drugs but now am a bit open to us now to solve my depression."
How many prior treatments have patients received?
| 1 | 100.0% |
Frequently Asked Questions
How many healthcare facilities are currently involved in the implementation of this trial?
"This trial is conducted in Douglas Mental Health University Institute (Verdun, Quebec), GMF Centre Médical Métro Monk (Montréal, Ontario), McGill University Health Care Centre (MUHC) in Toronto, Vermont and 16 other medical institutions." - Anonymous Online Contributor
How many individuals are being observed in this clinical trial?
"Affirmative. The clinicaltrials.gov website reflects that this trial, which was inaugurated on June 16th 2022 is currently recruiting participants. In total, the study requires 500 people from 16 locations to take part in the research." - Anonymous Online Contributor
Are recruitment efforts for this experiment ongoing?
"Affirmative. Clinicaltrials.gov displays that this research is presently enrolling patients; the trial was first made available on June 16th 2022, and last modified on September 26th 2022. The study requires 500 participants between 16 different sites to complete it" - Anonymous Online Contributor